Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Healthtrust
Baxter
Chubb
Daiichi Sankyo
Dow
Medtronic
Moodys
Accenture
Argus Health

Generated: May 26, 2018

DrugPatentWatch Database Preview

HUMALOG MIX 75/25 PEN Drug Profile

or, see our see our flat-rate plans

« Back to Dashboard

Which patents cover Humalog Mix 75/25 Pen, and what generic alternatives are available?

Humalog Mix 75/25 Pen is a drug marketed by Lilly and is included in one NDA.

The generic ingredient in HUMALOG MIX 75/25 PEN is insulin lispro protamine recombinant; insulin lispro recombinant. There are thirty-nine drug master file entries for this compound. Two suppliers are listed for this compound. Additional details are available on the insulin lispro protamine recombinant; insulin lispro recombinant profile page.
Summary for HUMALOG MIX 75/25 PEN
US Patents:0
Applicants:1
NDAs:1
Suppliers / Packagers:2
Clinical Trials:111
DailyMed Link:HUMALOG MIX 75/25 PEN at DailyMed
Drug patent expirations by year for HUMALOG MIX 75/25 PEN
Pharmacology for HUMALOG MIX 75/25 PEN
Ingredient-typeInsulin
Drug ClassInsulin Analog

US Patents and Regulatory Information for HUMALOG MIX 75/25 PEN

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Lilly HUMALOG MIX 75/25 PEN insulin lispro protamine recombinant; insulin lispro recombinant INJECTABLE;INJECTION 021017-003 Dec 22, 1999 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

or, see our see our flat-rate plans

or, see our see our flat-rate plans

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Colorcon
Citi
Boehringer Ingelheim
US Department of Justice
Fuji
Teva
Cantor Fitzgerald
Dow
Julphar

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.